Sanofi to cut in­sulin prices for unin­sured from $99 to $35, match­ing the in­sulin cap com­ing through Con­gress

As the House-passed bill to cap the month­ly price of in­sulin at $35 na­tion­wide makes its way for a Sen­ate vote soon, Sanofi an­nounced Wednes­day morn­ing that be­gin­ning next month it will cut the month­ly price of its in­sulins for unin­sured Amer­i­cans to $35, down from $99 pre­vi­ous­ly.

The an­nounce­ment from Sanofi, which al­lows the unin­sured to buy one or mul­ti­ple Sanofi in­sulins (Lan­tus, In­sulin Glargine U-100, Tou­jeo, Ad­mel­og, and Apidra) at $35 for a 30-day sup­ply ef­fec­tive Ju­ly 1, fol­lows House pas­sage (232-193) of the month­ly cap in March, with just 12 Re­pub­li­cans vot­ing in fa­vor of the mea­sure.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.